Disease expenditure in Australia 2019–20 analyses Australia’s national health spending to provide additional detail about the people receiving care and the conditions and diseases being treated.
2019–20 data is presented using Australian Burden of Disease Study (ABDS) conditions including COVID–19, with spending reported by health care sector, type of condition, age group, and sex. Information is presented on the web pages using interactive visualisations, and a downloadable Microsoft Excel workbook.
- Cat. no: HWE 90
Findings from this report:
-
Musculoskeletal disorders are responsible for more health spending than any other group of conditions ($14.6 billion)
-
Cardiovascular diseases ($12.7 billion) and cancer and other neoplasms ($12.1 billion) ranked 2nd and 3rd highest
-
Mental and substance use disorders overtook injuries in 2019–20 as the 4th highest disease group for spending
-
$183 million was spent on COVID–19 with $87 million spent through hospitals and $96 million through pathology testing